Subscribe
Be the first with the news that moves the market- Moss Genomics (MOSS) has launched its cognitive health test
- The cognitive health report assesses the genetic markers associated with the ability to clearly think, learn, and remember
- The report analyzes up to 80 million genetic variants to provide insightful information on cognitive health based on genetic information provided
- Moss Genomics (MOSS) opened trading at $0.25
The cognitive health report assesses the genetic markers associated with the ability to clearly think, learn, and remember.
The report analyzes up to 80 million genetic variants to provide insightful information on cognitive health based on genetic information provided. The customer receives six reports delivering insight on cognitive health which highlight cognitive function, problem solving ability, memory performance, education, impulsivity, and brain fog.
Moss Doctoral student, Supakan Kate Apiratanapimonchai explained that cognitive health plays a crucial role in our daily lifestyle and is often overlooked.
“The brain is the main source of our daily functions such as making decisions, problem-solving, and communication. Our brain is considered a valuable organ because it directs and is in charge of the next move for all parts in the human body. Many of us take vitamin supplements for other systems of our body but not very many take care of their brain health.”
The company’s president, Michelle Lee, added that the cognitive health report assesses the genetic markers associated with the ability to clearly think, learn, and remember.
“A healthy brain is one that can perform all the mental processes that are collectively known as cognition, including the ability to learn new things, intuition, judgment, language, and remembering.”
This is the first report by the company made available to customers focused on mental health and is available to purchase via Moss’ website.
Moss Genomics Inc. (MOSS) is a consumer genomics company that offers personalized health, anti-aging, and wellness offerings guided by genomic, microbiome, and epigenome data.
Moss Genomics (MOSS) opened trading at $0.25.
